Brad's Biorunup - New Portfolio

Lazy Brad

Brad's Biorunup
Individual Investor
Ranked #396,756 out of 828,236 TipRanks' Investors
Success Rate
59%
27 out of 46
profitable transactions
Average Return
3.58%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 3.79%
6-Month Return▲ 37.16%
12-Month Return-
YTD Return▲ 33.05%
Total Return▲ 33.05%

Best Trade

Opened at
Closed at-
Gain▲ 86.85%

Bio

As a serious and responsible investor, I secured my assets in a classic Lazy Portfolio, the old good 60/40. Can you imagine how boring it is? So the Mr. Hyde in me diverted some pocket $$ from it to cherry-pick this bunch of risky, volatile stocks.

Performance

32.43%0-32.43%
▲ 0.80%
▼ 0.87%
▲ 14.72%
Apr 2025
▲ 11.64%
▲ 6.28%
▲ 32.43%
May 2025
▲ 9.25%
▲ 5.14%
▼ 2.25%
Jun 2025
▲ 7.60%
▲ 2.30%
▼ 3.64%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 1.90%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 8.95%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 4.48%
Oct 2025
▼ 2.81%
▲ 0.19%
▼ 5.89%
Nov 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 0.80%▼ 0.87%▲ 14.72%
▲ 11.64%▲ 6.28%▲ 32.43%
▲ 9.25%▲ 5.14%▼ 2.25%
▲ 7.60%▲ 2.30%▼ 3.64%
▲ 2.76%▲ 2.05%▲ 1.90%
▲ 12.88%▲ 3.56%▲ 8.95%
▲ 10.96%▲ 2.38%▲ 4.48%
▼ 2.81%▲ 0.19%▼ 5.89%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
89bio
▲ 34.79%
3
Close
Oct 29, 2025
ProKidney
0%
▼ 30.70%
1
Open
Oct 19, 2025
Syndax Pharmaceuticals
0%
▲ 7.00%
1
Open
Oct 19, 2025
Kura Oncology
0%
▲ 29.45%
1
Open
Sep 19, 2025
Vanda
0%
▼ 3.34%
1
Open
Sep 19, 2025
Exelixis
0%
▲ 5.61%
1
Open
Sep 19, 2025
Intuitive Surgical
0%
▼ 4.09%
2
Sell
Sep 18, 2025
DoorDash
▲ 40.83%
3
Close
Sep 18, 2025
Biomea Fusion
0%
▼ 37.98%
1
Open
Sep 18, 2025
Fortress Biotech
0%
▼ 30.06%
1
Open
Sep 18, 2025
Arcutis Biotherapeutics
0%
▲ 29.08%
1
Open
Sep 18, 2025
Cidara Therapeutics
0%
▲ 48.82%
1
Open
Sep 18, 2025
Apogee Therapeutics
0%
▲ 63.86%
1
Open
Sep 18, 2025
Celldex
0%
▼ 8.49%
1
Open
Sep 18, 2025
Aclaris Therapeutics
0%
▲ 18.97%
1
Open
Sep 18, 2025
Adagio Medical Holdings
0%
▼ 55.22%
1
Open
Sep 18, 2025
Imunon
▲ 12.37%
2
Close
Jun 19, 2025
Doximity
▼ 1.21%
2
Close
Jun 19, 2025
Urogen Pharma
▲ 71.37%
2
Close
Jun 13, 2025
Protagonist Therapeutics
▲ 1.24%
2
Close
Jun 13, 2025